Deletion mutants of human apolipoprotein A-I (apo hA-I) have been prod
uced from a bacterial expression system to explore the function of the
specific domains comprising residues 1-43, 1-65, 88-98, and 187-243,
respectively, in the lipid-free conformation and in the lipid-binding
mechanism of apo hA-I. Initial studies on apo Delta(1-43)A-I and apo D
elta(187-243)A-I have already been reported. To aid purification of th
ese mutants, a histidine-containing N-terminal extension was incorpora
ted (+his); in cases where comparison with the (-his) construct was po
ssible, little effect on the physical properties due to the (+his) ext
ension was found. All mutants have folded structures in their lipid-fr
ee state, however these structures differ widely in their relative the
rmodynamic stability and extent of secondary structure. The mutant wit
h the fewest residues deleted, apo Delta(88-98)A-I(+his), has the leas
t secondary structure (only 34% helix) and is also the least stable (D
elta G = 2.9 kcal/mol). Determined from sedimentation velocity measure
ments on the lipid-free proteins, all but apo Delta(1-65)A-I(+his) exh
ibited a range of conformers in solution, which fluctuated around a hi
ghly elongated species (dimensions equal to similar to(14-16) x simila
r to 2.3 nm). Apo Delta(1-65)A-I(+his) exhibited a discrete species wh
ich was less asymmetric (dimensions equal to 9 x 2.9 nm). Apo a(88-98)
A-I(+his) showed extreme heterogeneity with no predominating conformer
, Spectroscopic studies (ANS binding and circular dichroism) indicate
that there is little difference in the lipid-free structure of the car
boxy-terminal deletion mutant, apo Delta(187-243)A-I(+/-his) compared
to wildtype (wt) apo wtA-I(+/-his), but substantial differences are ob
served between wt and the amino-terminal deletion mutants, apo a(1-43)
A-I, apo a(1-65)A-I(+his), and apo Delta(88-98)A-I(+his), In contrast,
the lipid-binding properties are impaired for apo Delta(187-243)A-I(/-his), as measured by dimyristoyl phosphatidylcholine (DMPC) liposome
turbidity clearance kinetics and palmitoyloleoyl phosphatidylcholine
(POPC) equilibrium binding. Apo Delta(1-43)A-I, apo Delta(1-65)A-I(+hi
s), and apo Delta(88-98)A-I(+his) show lipid affinities statistically
similar to apo wtA-I(fhis), but significantly defective DMPC clearance
kinetics. Interestingly, lecithin:cholesterol acyltransferase (LCAT)
activation results correlate qualitatively with the lipid-binding affi
nity for all mutants but apo Delta(88-98)A-I(+his), suggesting that th
is mutant has an altered and possibly noncooperative lipid-bound struc
ture as well as an altered lipid-free structure, These results suggest
helix 1 (residues 44-65) and helix 10 (residues 220-240) are both req
uired for native lipid-binding properties, while the presence of inter
nal residues, at least helix 3 (residues 88-98), is essential for prop
er folding of both the lipid-free and lipid-bound conformations. Impor
tantly, studies on apo a(88-98)A-I(+his) provide the first experimenta
l evidence that a native-like structure is not necessary for native-li
ke lipid affinity, but apparently is necessary for both DMPC solubiliz
ation and LCAT activation. These results provide support for a hypothe
tical, multistep structure-based mechanism for apo hA-I lipid binding.